In this webinar I provide an overview of counterfeits in America, I talk about some myths of importation, and I teach patients and patient advocates some great tips for saving money safely.
In this presentation, Director of National Outreach Shabbir Imber Safdar reviews the current state of counterfeit drugs in America today, discusses some of the myths surrounding importation, and provides tips for saving money safely on the cost of prescription drugs.
Counterfeit drugs pose a major global problem and public health risk. According to the World Health Organization, over half of counterfeit drug cases found no active ingredients, while others contained incorrect or dangerous ingredients. Developing countries are especially impacted, with up to 60% of reported counterfeit drugs. Counterfeiting undermines healthcare systems and can have deadly consequences. The document warns that weak drug regulation and an unsecured supply chain allow for counterfeits to proliferate. It advocates purchasing from authorized drug distributors only to help strengthen oversight of the pharmaceutical supply system.
The document discusses the dangers American patients face from counterfeit medications obtained outside of the regulated US drug supply chain, such as through fake online Canadian pharmacies. It details how breaks in the secure supply chain, such as patients buying drugs online or some doctors and pharmacists obtaining drugs from unlicensed distributors, can endanger patients by exposing them to counterfeit and unsafe medications. The document aims to dispel myths about obtaining cheaper drugs from outside the US and provides tips for patients to stay safe.
Healthcare providers are increasingly breaking the secure supply chain and endangering patients. Learn about counterfeit drugs and most recent incidents involving providers.
Also learn about how you can be a part of the solution by working with the Partnership for Safe Medicines.
A presentation by J. Aaron Graham, Executive Director of Brand Safety & Security at Boehringer Ingelheim Pharmaceuticals, Inc., about the threat of imported counterfeit prescription drugs.
This presentation is designed to train patient advocates in the safety issues around counterfeit drugs: how counterfeits enter our supply chain and how patients can protect themselves.
Counterfeit drugs: what a doctor should knowMark Davison
Short lecture to medical students on risks, prevalence and detection of fake medicines and protection of patient safety. Essential training for new doctors and pharmacists.
In this presentation, Director of National Outreach Shabbir Imber Safdar reviews the current state of counterfeit drugs in America today, discusses some of the myths surrounding importation, and provides tips for saving money safely on the cost of prescription drugs.
Counterfeit drugs pose a major global problem and public health risk. According to the World Health Organization, over half of counterfeit drug cases found no active ingredients, while others contained incorrect or dangerous ingredients. Developing countries are especially impacted, with up to 60% of reported counterfeit drugs. Counterfeiting undermines healthcare systems and can have deadly consequences. The document warns that weak drug regulation and an unsecured supply chain allow for counterfeits to proliferate. It advocates purchasing from authorized drug distributors only to help strengthen oversight of the pharmaceutical supply system.
The document discusses the dangers American patients face from counterfeit medications obtained outside of the regulated US drug supply chain, such as through fake online Canadian pharmacies. It details how breaks in the secure supply chain, such as patients buying drugs online or some doctors and pharmacists obtaining drugs from unlicensed distributors, can endanger patients by exposing them to counterfeit and unsafe medications. The document aims to dispel myths about obtaining cheaper drugs from outside the US and provides tips for patients to stay safe.
Healthcare providers are increasingly breaking the secure supply chain and endangering patients. Learn about counterfeit drugs and most recent incidents involving providers.
Also learn about how you can be a part of the solution by working with the Partnership for Safe Medicines.
A presentation by J. Aaron Graham, Executive Director of Brand Safety & Security at Boehringer Ingelheim Pharmaceuticals, Inc., about the threat of imported counterfeit prescription drugs.
This presentation is designed to train patient advocates in the safety issues around counterfeit drugs: how counterfeits enter our supply chain and how patients can protect themselves.
Counterfeit drugs: what a doctor should knowMark Davison
Short lecture to medical students on risks, prevalence and detection of fake medicines and protection of patient safety. Essential training for new doctors and pharmacists.
The document discusses the issue of counterfeit prescription drugs, particularly those imported from other countries. It notes that while the FDA's drug distribution system in the US is considered the safest in the world, the number of counterfeit drug cases has risen in recent years. The FDA ordered drugs from a website claiming to offer cheaper generics from Canada, but testing showed the drugs actually came from China and were either too strong or weak, or contained dangerous impurities. Importing drugs from other countries is not safe and raises legal and health issues.
Tim Mackey, Assistant Professor, University of California, San Diego - Department of Anesthesiology, speaks about the effect counterfeit Avastin has had on efforts to protect the American public from counterfeit medications.
Scott A. LaGanga, Executive Director Partnership for Safe Medicines (PSM) and Senior Vice President, Public Affairs -Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA), opens PSM's Interchange 2014.
This document discusses Maine's experience with LD 171, a law passed in 2013 to legalize the importation of prescription drugs from licensed pharmacies in Canada, UK, Australia and New Zealand. It describes how the Maine Pharmacy Association President ordered drugs from an online Canadian pharmacy called Canada Drug Center and found the drugs to be substandard and contaminated. The law was struck down in 2015 because it compromised federal drug regulation. Attempts by other states to import drugs from foreign pharmacies similarly found poor oversight, unsafe drugs, and an inability to regulate foreign entities.
The document provides information on counterfeit drugs, including definitions, global and Indian statistics, examples of counterfeited drugs, and potential solutions. Some key points:
- The WHO defines counterfeit drugs as deliberately mislabeled regarding identity and/or source, and they may contain incorrect ingredients, insufficient active ingredients, or no active ingredients.
- India accounts for 10% of global drug production but also has high rates of counterfeiting, estimated at 20% of drugs. Globally, counterfeiting costs the legitimate pharmaceutical industry $75 billion annually.
- Many popular drugs are frequently counterfeited, such as Viagra, Lipitor, and cancer treatments. Counterfeits are found to contain
A presentation by Tom T. Kubic, President and CEO, Pharmaceutical Security Institute and Treasurer, Partnership for Safe Medicines about the threat of imported counterfeit prescription drugs.
This document discusses the threats posed by counterfeit medicines. It provides several examples of counterfeit medicines breaching the US supply chain and being distributed through "Canadian" websites and social media sites. The counterfeits have been found to contain no active ingredients, toxic ingredients, or incorrect doses of active ingredients. They are manufactured under unsafe conditions but can appear virtually indistinguishable from real medicines. The document emphasizes that counterfeit medicines pose a real threat to patient health and safety.
Pesticides for Marijuana Cannabis Plants - Ban Them All Today!Cannabis News
Why we should ban all marijuana pesticide use today, no pesticides on cannabis plants, read this https://cannabis.net/blog/opinion/ban-all-pesticides-from-cannabis-today
Securing the Global Pharmaceutical Supply Chain against the Threat of Counter...Yasmin AbdelAziz
In 2012, counterfeit versions of the cancer drug
Avastin were found in 19 American treatment
centers. The impostor drug lacked the active
ingredient, rendering it virtually useless for
treatment purposes.
I have been working on the topic of anti-counterfeiting for a number of years and find myself increasingly engrossed and thoroughly surprised as our understanding of this topic grows. The imagination and the brutality with which the criminal industry produces, distributes and sells imitation goods is unmatched. The consequences of such dire acts are not only killing children but also affecting the lives of many and fighting such forgery has become a personal battle for me.
A Pennsylvania pharmacist testified that only generic drug makers are benefiting from large price increases for generic medications. The pharmacist cited drug shortages, industry consolidation, and fewer manufacturers as reasons for the price hikes, with some generics increasing in price by as much as 8,000%. A government investigation into the sudden price increases was announced. An analysis found that more than 12,000 generic drugs have seen dramatic price rises in the last 18 months, hardest hit being patients paying out of pocket for prescriptions.
Prescription Drug Abuse is on the Rise in FloridaCraig Benoit
Between 2005 and 2009, deaths caused by nonmedical prescription drugs increased across Florida. Broward and Palm Beach Counties were among the hardest hit areas. The number of deaths involving opioids like oxycodone and methadone rose substantially over this period. Oxycodone deaths increased 249% from 2005 to 2009. Broward County had the highest number of prescription drug deaths of any Florida county. Nonmedical use of prescription opioids is a growing problem impacting South Florida and the state.
This document discusses the Partnership for Safe Medicines, an organization advocating for safe medication access. It lists over 100 member organizations and provides information on counterfeit drugs including examples during the COVID-19 pandemic of fake vaccines, testing kits, and medicines being sold. Data is presented on rising drug overdose deaths in the US driven largely by fentanyl, and examples are given of recent seizures of counterfeit pills containing fentanyl in various states and countries that are fueling the opioid crisis.
This lecture discusses health policy related to curbing abuse of controlled substances - like narcotics. This article discusses several steps Utah has made to decrease the number of opiate-related deaths.
Marijuana is a plant whose flowers and leaves can be dried and consumed. It contains THC which causes intoxication when used. Over 100 million Americans have tried marijuana, and 14 million use it daily despite risks of legal prosecution. Marijuana has medical benefits and can treat conditions like cancer and glaucoma. Legalizing marijuana could generate tax revenue, reduce criminal activity of drug dealers and cartels, and free up law enforcement to focus on more dangerous drugs. The NORML organization advocates for marijuana law reform and educates the public on the benefits of legalizing marijuana.
This document raises concerns about efforts to legalize marijuana for medical and recreational use. It argues that marijuana legalization is being driven more by business and political interests than concerns for patient health, as smoked marijuana has not gone through the FDA approval process required for other medicines. Legalizing medical marijuana could open the door to legalizing recreational use and lead to public health and financial costs for employers. It encourages sharing information to educate communities and prevent Florida from legalizing marijuana.
Dr Sabet Power Point Final Sept 23, 2013Heidi Denton
This document summarizes current drug use trends in the United States, with a focus on prescription drug abuse. It finds that prescription drug abuse is a major problem, with opioids like oxycodone and hydrocodone involved in most drug overdose deaths. It also discusses trends in other drugs like cocaine, heroin, methamphetamine, and marijuana. Prevention efforts discussed include education, prescription drug monitoring programs, proper medication disposal, and enforcement against "pill mills."
June 19, 2013: This presentation to highlight the dangers of counterfeit drugs to Maine patients was given to the Bangor Dept. of Health Public Advisory committee
Fighting black market and counterfeit drugs in America endangers patients. Any break in the regulated, closed supply chain - whether by patients buying drugs online, or medical professionals purchasing from unlicensed distributors - puts lives at risk. Counterfeit or improperly handled treatments for conditions like HIV/AIDS, osteoporosis, kidney disease, and diabetes can be ineffective or even life-threatening when patients' health depends on properly manufactured and stored medicine. Protecting the supply chain is crucial to patient safety.
The document discusses the issue of counterfeit prescription drugs, particularly those imported from other countries. It notes that while the FDA's drug distribution system in the US is considered the safest in the world, the number of counterfeit drug cases has risen in recent years. The FDA ordered drugs from a website claiming to offer cheaper generics from Canada, but testing showed the drugs actually came from China and were either too strong or weak, or contained dangerous impurities. Importing drugs from other countries is not safe and raises legal and health issues.
Tim Mackey, Assistant Professor, University of California, San Diego - Department of Anesthesiology, speaks about the effect counterfeit Avastin has had on efforts to protect the American public from counterfeit medications.
Scott A. LaGanga, Executive Director Partnership for Safe Medicines (PSM) and Senior Vice President, Public Affairs -Advocacy at the Pharmaceutical Research and Manufacturers of America (PhRMA), opens PSM's Interchange 2014.
This document discusses Maine's experience with LD 171, a law passed in 2013 to legalize the importation of prescription drugs from licensed pharmacies in Canada, UK, Australia and New Zealand. It describes how the Maine Pharmacy Association President ordered drugs from an online Canadian pharmacy called Canada Drug Center and found the drugs to be substandard and contaminated. The law was struck down in 2015 because it compromised federal drug regulation. Attempts by other states to import drugs from foreign pharmacies similarly found poor oversight, unsafe drugs, and an inability to regulate foreign entities.
The document provides information on counterfeit drugs, including definitions, global and Indian statistics, examples of counterfeited drugs, and potential solutions. Some key points:
- The WHO defines counterfeit drugs as deliberately mislabeled regarding identity and/or source, and they may contain incorrect ingredients, insufficient active ingredients, or no active ingredients.
- India accounts for 10% of global drug production but also has high rates of counterfeiting, estimated at 20% of drugs. Globally, counterfeiting costs the legitimate pharmaceutical industry $75 billion annually.
- Many popular drugs are frequently counterfeited, such as Viagra, Lipitor, and cancer treatments. Counterfeits are found to contain
A presentation by Tom T. Kubic, President and CEO, Pharmaceutical Security Institute and Treasurer, Partnership for Safe Medicines about the threat of imported counterfeit prescription drugs.
This document discusses the threats posed by counterfeit medicines. It provides several examples of counterfeit medicines breaching the US supply chain and being distributed through "Canadian" websites and social media sites. The counterfeits have been found to contain no active ingredients, toxic ingredients, or incorrect doses of active ingredients. They are manufactured under unsafe conditions but can appear virtually indistinguishable from real medicines. The document emphasizes that counterfeit medicines pose a real threat to patient health and safety.
Pesticides for Marijuana Cannabis Plants - Ban Them All Today!Cannabis News
Why we should ban all marijuana pesticide use today, no pesticides on cannabis plants, read this https://cannabis.net/blog/opinion/ban-all-pesticides-from-cannabis-today
Securing the Global Pharmaceutical Supply Chain against the Threat of Counter...Yasmin AbdelAziz
In 2012, counterfeit versions of the cancer drug
Avastin were found in 19 American treatment
centers. The impostor drug lacked the active
ingredient, rendering it virtually useless for
treatment purposes.
I have been working on the topic of anti-counterfeiting for a number of years and find myself increasingly engrossed and thoroughly surprised as our understanding of this topic grows. The imagination and the brutality with which the criminal industry produces, distributes and sells imitation goods is unmatched. The consequences of such dire acts are not only killing children but also affecting the lives of many and fighting such forgery has become a personal battle for me.
A Pennsylvania pharmacist testified that only generic drug makers are benefiting from large price increases for generic medications. The pharmacist cited drug shortages, industry consolidation, and fewer manufacturers as reasons for the price hikes, with some generics increasing in price by as much as 8,000%. A government investigation into the sudden price increases was announced. An analysis found that more than 12,000 generic drugs have seen dramatic price rises in the last 18 months, hardest hit being patients paying out of pocket for prescriptions.
Prescription Drug Abuse is on the Rise in FloridaCraig Benoit
Between 2005 and 2009, deaths caused by nonmedical prescription drugs increased across Florida. Broward and Palm Beach Counties were among the hardest hit areas. The number of deaths involving opioids like oxycodone and methadone rose substantially over this period. Oxycodone deaths increased 249% from 2005 to 2009. Broward County had the highest number of prescription drug deaths of any Florida county. Nonmedical use of prescription opioids is a growing problem impacting South Florida and the state.
This document discusses the Partnership for Safe Medicines, an organization advocating for safe medication access. It lists over 100 member organizations and provides information on counterfeit drugs including examples during the COVID-19 pandemic of fake vaccines, testing kits, and medicines being sold. Data is presented on rising drug overdose deaths in the US driven largely by fentanyl, and examples are given of recent seizures of counterfeit pills containing fentanyl in various states and countries that are fueling the opioid crisis.
This lecture discusses health policy related to curbing abuse of controlled substances - like narcotics. This article discusses several steps Utah has made to decrease the number of opiate-related deaths.
Marijuana is a plant whose flowers and leaves can be dried and consumed. It contains THC which causes intoxication when used. Over 100 million Americans have tried marijuana, and 14 million use it daily despite risks of legal prosecution. Marijuana has medical benefits and can treat conditions like cancer and glaucoma. Legalizing marijuana could generate tax revenue, reduce criminal activity of drug dealers and cartels, and free up law enforcement to focus on more dangerous drugs. The NORML organization advocates for marijuana law reform and educates the public on the benefits of legalizing marijuana.
This document raises concerns about efforts to legalize marijuana for medical and recreational use. It argues that marijuana legalization is being driven more by business and political interests than concerns for patient health, as smoked marijuana has not gone through the FDA approval process required for other medicines. Legalizing medical marijuana could open the door to legalizing recreational use and lead to public health and financial costs for employers. It encourages sharing information to educate communities and prevent Florida from legalizing marijuana.
Dr Sabet Power Point Final Sept 23, 2013Heidi Denton
This document summarizes current drug use trends in the United States, with a focus on prescription drug abuse. It finds that prescription drug abuse is a major problem, with opioids like oxycodone and hydrocodone involved in most drug overdose deaths. It also discusses trends in other drugs like cocaine, heroin, methamphetamine, and marijuana. Prevention efforts discussed include education, prescription drug monitoring programs, proper medication disposal, and enforcement against "pill mills."
June 19, 2013: This presentation to highlight the dangers of counterfeit drugs to Maine patients was given to the Bangor Dept. of Health Public Advisory committee
Fighting black market and counterfeit drugs in America endangers patients. Any break in the regulated, closed supply chain - whether by patients buying drugs online, or medical professionals purchasing from unlicensed distributors - puts lives at risk. Counterfeit or improperly handled treatments for conditions like HIV/AIDS, osteoporosis, kidney disease, and diabetes can be ineffective or even life-threatening when patients' health depends on properly manufactured and stored medicine. Protecting the supply chain is crucial to patient safety.
What have been the major crimes and policy developments in the space of counterfeit medicines? PSM reviews major prosecutions and legislation from the first half of 2021.
Combating Counterfeit with a Patient PerspectiveSven Bergmann
Presentation from 7th Pharma Anti-Counterfeit and Brand Protection Summit in Philadelphia, PA. 26-28 March 2018.
The United States is considered to have the safest drug supply chain in the world. However, 19 million Americans purchase pharmaceuticals from outside of this supply chain, from online pharmacies and unlicensed sources. This presentation details some of the devastating patient cases of counterfeit medicine, as well as the legislation and organizations fighting to keep pharmaceuticals safe.
Online Access to Safe and Affordable Medication: Applying human rights law to...PharmacyChecker
Online Access to Safe and Affordable Medication: Applying human rights law to cyber rule-making and Internet governance
https://www.pharmacychecker.com/
Internet users are benefiting from online access to safe and affordable medications. The pharmaceutical industry views Internet access as a threat and disruptive to its profit model because consumers are paying less than the drug companies intended for them to pay. According to the UN Human Rights Council, access to affordable medication is a human right. As the Internet community seeks to infuse the principles of international human rights law into the discourse and practice of Internet governance it should help maintain the widest possible online access to safe and affordable medication.
https://www.pharmacychecker.com/
This study surveyed 36 patients in a residential addiction treatment program to understand the methods used to improperly obtain prescription medications from physicians. Key findings include:
- Patients obtained an average of 50 prescriptions over 3.8 years, seeing an average of 2 doctors in 1.2 different states and 5 pharmacies.
- The most common reasons for obtaining prescriptions from doctors rather than buying illegally were legal concerns and lower cost/increased comfort.
- The most obtained drug types were opioids (97% of patients) and sedative-hypnotics (47% of patients).
- The majority (75%) feigned symptoms to obtain prescriptions, with some using falsified medical records or
Marv Shepherd conducted research exploring whether hospital pharmacies could be a source of diverted drugs. A survey of Texas hospitals found that 25% reported being contacted by "grey market" vendors weekly or daily to purchase pharmaceuticals. Additionally, over 85% of hospitals reported being contacted by such vendors in the last month to sell drugs. While the size of this illicit market is unknown, the findings suggest some hospitals may be unlawfully diverting drugs. Further analysis found no significant associations between vendor contacts and hospital size, ownership, or location. The research indicates opportunistic vendors are actively trying to obtain drugs from some hospitals in Texas.
The document discusses the prescription drug abuse epidemic in the United States. It provides statistics showing the rise in overdose deaths from prescription painkillers between 1999 and 2008. Certain groups are more at risk of abusing or overdosing on these drugs. "Pill mills" dispensing prescription drugs with little oversight have flourished in Florida, fueling abuse in other states. Efforts are underway to address this crisis and crack down on pill mills.
The document discusses direct-to-consumer (DTC) advertising of prescription drugs in the United States. It provides background on the history of DTC advertising and FDA regulation. Both supporters and critics of DTC advertising are discussed. Supporters argue that it educates patients, prompts discussions with doctors, and empowers consumers, while critics argue that it can mislead patients and inappropriately influence them to request drugs. Spending on DTC advertising by the pharmaceutical industry has risen dramatically in recent decades.
The document discusses direct-to-consumer (DTC) advertising of prescription drugs in the United States. It provides background on the history of DTC advertising and FDA regulation. Both supporters and critics of DTC advertising are discussed. Supporters argue that it educates patients, prompts discussions with doctors, and empowers consumers, while critics argue that it can mislead patients and inappropriately influence them to request drugs. Spending on DTC advertising by the pharmaceutical industry has risen dramatically in recent decades.
The document discusses direct-to-consumer (DTC) advertising of prescription drugs in the United States. It provides background on the history of DTC advertising and FDA regulation. Both supporters and critics of DTC advertising are discussed. Supporters argue that it educates patients, prompts discussions with doctors, and empowers consumers, while critics argue that it can mislead patients and inappropriately influence them to request drugs. Spending on DTC advertising by the pharmaceutical industry has risen dramatically in recent decades.
The document discusses the prescription drug price crisis in the United States. Drug prices have risen much faster than general inflation over the past decade, and millions of Americans cannot afford necessary medications as a result. The U.S. pays significantly higher prices for many drugs than other countries. Several policy solutions are proposed to lower drug costs, including allowing Medicare to negotiate drug prices, banning "pay-for-delay" deals between drug companies, and legalizing importation of lower-cost drugs from abroad. Advocacy groups are calling for stronger political action to enact reforms and lower what Americans pay for prescription medications.
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...MedicineAndHealthUSA
This document provides information on reducing prescription drug costs for patients, including learning drug prices, using generic medications, slicing pills, selecting alternative medications, and assistance programs. It discusses specific cost-saving strategies like comparing prices online, using $4 generic programs, Medicare Part D, and pharmaceutical company assistance. The summary focuses on high-level strategies to help a sample patient who cannot afford his medications due to lack of prescription coverage.
Lawmakers call on nih to reduce price of cancer drug by Floyd Arthur (PPT)Floyd Arthur
A group of Democratic lawmakers urged the National Institutes of Health and Department of Health and Human Services to hold hearings on the high price of the prostate cancer drug Xtandi. Xtandi was developed with public funds from UCLA research but sells for $129,000 per year in the US, while being cheaper in other countries. The lawmakers want the agencies to revoke the patent and make the drug available at a lower price, since taxpayers funded its development. Drugmakers are increasingly under fire for soaring drug prices in the US.
This document discusses the history of drug regulation laws in the United States. It begins by covering early federal laws like the 1906 Pure Food and Drug Act that required labeling of drug contents but did little to regulate safety. The 1938 Food, Drug, and Cosmetic Act and later amendments in 1951 and 1962 strengthened regulations by requiring pre-market approval of drugs as safe and effective. The Controlled Substances Act of 1970 established a drug scheduling system to regulate substances based on abuse and medical potential. The document also discusses issues around legalization debates, prevention strategies, drug testing policies, and criticisms of discriminatory enforcement practices.
Safe Prescribing Practices Conference for Medical Professionals, June 2013Heidi Denton
Participants will:
Report their intent to support and/or actively work towards incorporating best practices in responsible prescribing guidelines into their everyday practice of medicine.
Report an increased knowledge of the Michigan Automated Prescription System (MAPS) and the benefits of reporting regularly to MAPS.
Report intent to support and/or actively work towards incorporating consistent use of the MAPS into their everyday practice of prescribing controlled substances.
Report that at the training they received easy to use tools that can help them to better educate their patients on the importance of taking medications as prescribed.
Gain an increased knowledge of local, state, and national substance abuse and mental health treatment resources.
Drug Use, Regulation, and the LawChapter 3Guid.docxjacksnathalie
This document discusses guidelines for controlling drug development and marketing, including strategies for preventing drug abuse through supply reduction, inoculation, and demand reduction. It also summarizes regulations that have been implemented related to drug labeling, safety testing, and advertising in response to issues like fraudulent patent medicines and the thalidomide tragedy. Current drug scheduling is explained based on abuse potential and medical usefulness.
This document discusses concerns around safely implementing importation of drugs from Canada. It summarizes perspectives from experts in drug supply chain security and Canadian policy. They note that importation could undermine the Drug Supply Chain Security Act, as drugs from foreign markets don't use the same identifiers and documentation. It may also diminish Canada's drug supply and leave Americans without long-term solutions. The document outlines risks like counterfeiting and how Canadian authorities do not inspect all shipments. It questions whether importation could realistically work given these challenges to safety and oversight.
Herbal products in canada how safe are theyNazeer Mohd
Herbal products sold in Canada are largely unregulated as they are exempt from the drug review process if not registered as drugs. This places consumers at risk of side effects from adulterated or ineffective herbal products. While perceived as natural and safe, herbal therapies can be harmful, especially when used to replace conventional medical treatment. Physicians need to be aware of potential issues with herbal product use in order to advise patients.
PSM presented a special webinar for families affected by counterfeits and fentanyl. Learn about opportunities to make your voice heard. You can watch the presentation at https://youtu.be/FmBv3Bb7ZHI
This document discusses why importing prescription drugs from Canada is not a viable solution to high drug costs in the US. It notes that previous state-level importation programs failed due to lack of savings and inability to adequately regulate foreign pharmacies. Proper testing of imported drugs is very expensive and would consume any savings. There are also safety concerns, as importation would undermine track-and-trace systems and Canada's drug supply is already limited. Law enforcement experts warn that importation could exacerbate the opioid crisis and organized crime may exploit regulatory loopholes. The document argues policymakers should focus on real solutions rather than unrealistic importation proposals.
Linda I. Marks, Senior Litigation Counsel, Consumer Protection Branch, U.S. Department of Justice speaks around criminal prosecutions of drug counterfeiters and diverters in the US.
Daniel Burke, FDA's Senior Special Agent in the Cybercrime Investigations Unit, introduces our 3rd panel at the 2014 Interchange by speaking about how fake online pharmacies can affect American citizens.
Non-FDA approved foreign drugs are being provided to Massachusetts patients through online pharmacies, putting their health at risk. These drugs may contain toxic fillers, expired ingredients, or lack important safety information. Several health groups and trusts in Massachusetts are directing patients to these online pharmacies to reduce costs, incentivizing the purchase of unsafe drugs. Records obtained through FOIA requests show thousands of patients across multiple regions in Massachusetts are affected. Next steps include alerting regulatory agencies to intervene.
Marv Shepherd, PSM president, Member USP Package Storage and Distribution Expert Committee, and Professor at the University of Texas at Austin speaks about updates to United States Pharmacopeia's good distribution practices.
1. Partnership for Safe Medicines China (PSM China) was established in Beijing in November 2012 with participation from 12 associations to ensure a safe drug supply chain and educate patients and consumers on safe medication use.
2. PSM China's members include associations representing pharmaceutical manufacturers, distributors, hospitals, and licensed pharmacists.
3. In 2014, PSM China collaborated with Partnership for Safe Medicines India, launched a website, focused education efforts on medication for the elderly and chronic diseases, and organized over 180 volunteers to support educational programs.
The document discusses Maine laws regarding importing prescription drugs from licensed pharmacies in other countries. It states that licensed pharmacies in Canada, UK, Australia, and New Zealand can export prescription drugs by mail to Maine residents for personal use without a Maine license. It also states that entities that facilitate drug exports from these licensed foreign pharmacies to Maine residents are also exempt from needing a Maine license. The document then lists information about specific drugs' manufacturers, fill centers, and mailing addresses.
Tom Kubic, President and CEO of the Pharmaceutical Security Institute (PSI) and PSM board member, presents an overview of global activity in the counterfeiting of prescription medicines in 2013.
Libby Baney, Executive Director for the Alliance for Safe Online Pharmacies talks about the current state of rogue online pharmacies and efforts to curb them.
The document summarizes a panel discussion on new developments in international cooperation to address challenges related to unapproved and counterfeit drugs. It describes problems like large quantities of prescription drugs coming from other countries and physicians ordering directly from unlicensed suppliers. Global challenges in investigations like tracing money and packages and obtaining evidence from other countries are also outlined. The panelists discuss international enforcement operations and USP programs that help strengthen quality assurance in developing countries.
PSM India aims to: raise awareness of spurious drugs' harm; educate consumers and practitioners on drug quality and identifying suspected spurious drugs; and collaborate with the government and WHO. PSM held an international workshop on ensuring patient safety over commercial interests and regaining consumer confidence. A study found many small manufacturers lack Good Manufacturing Practices compliance and risk producing spurious drugs. It evaluated 348 essential drugs across India to understand the spurious drug problem's full extent and compliance with regulations. PSM plans to expand detection technologies statewide and work with regulators against law-violating manufacturers.
This document summarizes a panel discussion on issues related to fake online pharmacies. The panelists included pharmacists, law enforcement agents, and policy experts. They discussed how online pharmacies are difficult to regulate due to their ability to operate across state and international lines. While organizations like the FDA and NABP have programs to verify legitimate online pharmacies, illicit sites still proliferate using search engines, social media, and other online marketing techniques. Research presented found that consumers have difficulty identifying unsafe pharmacy websites and are willing to purchase medicines from illegal online pharmacies without prescriptions, including drugs that require close medical supervision.
The document discusses how American patients have been impacted by unsafe and counterfeit medicines from 2010-2013. It describes several cases where medical professionals purchased non-FDA approved drugs and devices, exposing patients to risks. This includes expired, stolen, or improperly stored medicines. The document outlines issues with specific treatments like IUDs, Botox, osteoporosis drugs, HIV drugs, and diabetes treatments. Patients who received counterfeit versions faced potential health problems. While the full scope of the counterfeit drug problem in the US is unknown, the document argues it threatens patient safety when healthcare providers and patients cannot be certain the treatments they receive are real and effective.
Tim Mackey presented on the availability of dangerous, unapproved, and recalled drugs online. Some key points:
- Research has found narrow therapeutic index drugs, drugs not approved for sale, and drugs under global recall are actively being marketed for sale without a prescription online.
- The online drug ecosystem is complex, involving affiliate networks, business-to-business sellers, and emerging technologies like the dark web.
- Moving forward, efforts should identify high-risk dangerous drugs, develop global lists of such drugs, map the entire illicit online pharmacy ecosystem, and prioritize enforcement against the worst offenders. The goal is to improve identification, surveillance and enforcement of clearly dangerous medicines available online without oversight.
The document summarizes the 2013 Interchange conference hosted by the Partnership for Safe Medicines (PSM). It lists the executive director of PSM and its many member organizations. It then describes PSM's efforts over the past year to educate over 300,000 patients, nurses, doctors and pharmacists, and nearly 1,000 at-risk clinics about counterfeit drugs through Facebook ads, printed materials, and trainings. PSM has also been working with international partners in countries like India, China, and Brazil. The conference agenda includes a new panel format and presentations on new research studies.
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central19various
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
2. PSM Members
Academy of Managed Care Pharmacy
Alaska Pharmacists Association
The ALS Association
American Association for Homecare
American College Health Association
American Pharmacists Association
American Society of Health System Pharmacists
Arizona Pharmacy Alliance (AzPA)
Association of Nurses in AIDS Care
BioForward
Biotechnology Industry Organization
California Healthcare Institute
California Pharmacists Association
California Society of Health-System Pharmacists
(CSHP)
Colorado Bioscience Association
Community Access National Network
The Council for Affordable Health Insurance
European Federation of Pharmaceutical Industries
and Associations (EFPIA)
Generic Pharmaceutical Association
Global Medicines Program
Healthcare Distribution Management Association
HealthCare Institute of New Jersey
Healthcare Leadership Council
The Hispanic Institute
Illinois Pharmacists Association
Institute of Health Law Studies
Institute for Safe Medication Practices
International Anti-Counterfeiting Coalition
International Federation of Pharmaceutical
Manufacturers and Associations
International Healthcare Facility Diversion
Association
Kidney Cancer Association
The Latino Coalition
The Life Raft Group
Maine Pharmacists Association
Maine Society of Health-System Pharmacists
(MSHP)
Maryland Pharmacists Association
Men’s Health Network
Minnesota Pharmacists Association
Missouri Pharmacy Association
National Alliance for Hispanic Health
National Alliance On Mental Illness
Maryland Pharmacists Association
National Association of Boards of Pharmacy
National Association of Chain Drug Stores
National Association of Drug Diversion
Investigators
National Association of Manufacturers
National Alliance of State Pharmacy Associations
National Biopharmaceutical Security Council
National Community Pharmacists Association
National Grange of the Patrons of Husbandry
National Latina Health Network
NeedyMeds
New York State Council of Health-system
Pharmacists (NYSCHP)
North Carolina Association of Pharmacists
Oklahoma Pharmacists Association
Parenteral Drug Association
PDMA Alliance
Pennsylvania Pharmacists Association
Pennsylvania Society of Health-system
Pharmacists
Pharmaceutical Industry Labor Management
Association (PILMA)
Pharmacist Planning Services
Pharmaceutical Security Institute.
PhRMA
RetireSafe
San Diego Center for Patient Safety
Spina Bifida Association of America
Texas Pharmacy Association
Texas Society of Health-System Pharmacists
United States Chamber of Commerce
University of New England College of Pharmacy
University of Texas Pharmacy School
Vietnam Veterans of America
Virginia Pharmacists Association
Vermont Pharmacists Association
West Virginia Rx
WomenHeart
To have your nonprofit join
PSM, contact
shabbir@safemedicines.org
10. Black market IUDs
Patients typically do not see the IUD before it’s surgically inserted. Nor do
they have the ability to check it or remove it should they become
concerned.
Doctors and clinics in 45 states (in
red) received warnings from the
FDA about purchasing fake IUDs.
Doctors and clinics in 8 states (in
orange) were convicted trafficking
in fake IUDs.
11. Black market oncology medication
The unlicensed wholesalers that
trafficked in Betty Hunter’s fake oncology
medication were finally sentenced in
2014, three years after her death in 2011.
The problem is far from solved. Since
2012, the FDA has warned 1,205 medical
practices in 47 states and the District of
Columbia that they had done business
with unlicensed distributors who had
been found selling counterfeit oncology
medication.
Betty Hunter before her death in 2011 (top)
Betty Hunter’s son describes his mother’s
gruesome reaction to her untreated cancer for
the TV Special “Lethal Fake Medicine” by
Bullitt Film (bottom)
27. Use medication assistance programs
www.needymeds.org
www.pparx.org
NeedyMeds provides a free prescription discount
card that can be used in all 50 states in the US.
The Partnership for Prescription Assistance® may
help patients who are uninsured or underinsured
access the medicines they need through the
program that is right for them – free of charge. Many
patients will get their medications for free or nearly
free.